Inflammatory Challenge in Human Aggression. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Inflammatory Challenge in Human Aggression. — Stella

Home/Intermittent Explosive Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Intermittent Explosive Disorder trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

The Ohio State University Medical Center, Columbus, Ohio

Key details

Phase

Safety & dosing

Sponsor

Ohio State University

Collaborators

National Institute of Mental Health (NIMH)

Enrollment target

~112 participants

Started

February 2026

Primary completion

July 2029

Age range

21 Years – 55 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.